Home Business Controversy over Sanofi’s statement about a possible COVID-19 vaccine

Controversy over Sanofi’s statement about a possible COVID-19 vaccine

<p><&excl;-- BEGIN THEIA POST SLIDER --><&sol;p>&NewLine;<p>The president of the French pharmaceutical company Sanofi&comma; Serge Weinberg&comma; confirmed on Thursday that the company will ensure that any vaccine against &&num;8220&semi;Covid-19&&num;8221&semi;&comma; once approved&comma; reaches all parts of the world at the same time&period; &&num;8220&semi;No country will receive a deposit&comma;&&num;8221&semi; Weinberg told the French Channel 2&period;<&sol;p>&NewLine;<blockquote class&equals;"td&lowbar;quote&lowbar;box td&lowbar;box&lowbar;center"><p>Serge Weinberg  said&colon; &&num;8220&semi;We are organized and have several manufacturing units&comma; some in the United States&comma; but many in Europe and France&&num;8221&semi; &period;<&sol;p><&sol;blockquote>&NewLine;<p>These words of assurance come after previous statements by Paul Hudson CEO of the Sanofi Pharmaceuticals Group on the priority given to the distribution of a possible vaccine for &&num;8220&semi;Covid-19&&num;8221&semi; in the United States&comma; which has caused great dissatisfaction in the world&comma; and called on several officials and organizations to distribute &&num;8220&semi;fair and global&&num;8221&semi; in case a vaccine is reached&period;<&sol;p>&NewLine;<p>Sanofi is a French group with 100&comma;000 employees at 73 industrial sites in 32 countries&comma; and the French laboratory represents one of the world&&num;8217&semi;s largest groups specializing in vaccines&period; Work began in mid-February on a new vaccine against the Coronavirus with the announcement of the signing of a cooperation agreement with the Advanced Biomedical Research and Development Authority affiliated to the American Department of Health&period;<&sol;p>&NewLine;<p>Thanks to this financial contribution&comma; the United States will have &&num;8220&semi;the right to obtain large pre-orders&&num;8221&semi; and will also be able to benefit from the vaccine several days or weeks before the rest of the world&comma; according to former Director-General Paul Hudson in an interview with Bloomberg&period;<&sol;p>&NewLine;<p>French President Emmanuel Macron said Thursday that the possible vaccine against the &&num;8220&semi;Covid-19&&num;8221&semi; epidemic should not be subject to &&num;8220&semi;market laws&&num;8221&semi;&period; The Elysee Palace also argues the group&&num;8217&semi;s statements had &&num;8220&semi;shocked everyone working &lpar;on the fight against the virus&rpar;&comma; including the president&&num;8221&semi;&comma; who will meet with Sanofi officials early next week&period;<&sol;p>&NewLine;<p>For its part&comma; the European Commission has confirmed that the vaccine against the emerging coronavirus must be &&num;8220&semi;universal&&num;8221&semi;&period; &&num;8220&semi;The Covid-19 vaccine must be in the public interest and its access must be fair and complete&comma;&&num;8221&semi; said the UNHCR spokesperson&period;<&sol;p>&NewLine;<p>The Commission has&comma; in fact&comma; organized a global donation to finance the search for a vaccine against the virus which has raised nearly 8 billion euros&period; The American government&comma; on the other hand&comma; did not participate in the donation and preferred to act alone&period;<&sol;p>&NewLine;<p>The argument went out of the political space and the non-governmental organization &&num;8220&semi;Oxfam&&num;8221&semi; criticized the financial motives and the pursuit of profits by the giant companies in the pharmaceutical industry&period;<&sol;p>&NewLine;<p>Faced with these reactions&comma; the French government quickly adopted a firm position&period; Secretary of State to the Minister of Economy and Finance Agnès Pannier-Runacher immediately confirmed that she had contacted &&num;8220&semi;Sanofi&&num;8221&semi; and obtained confirmation that the vaccine would be available to everyone&period;<&sol;p>&NewLine;<p><a href&equals;"https&colon;&sol;&sol;ustopbusiness&period;com&sol;wp-content&sol;uploads&sol;2020&sol;05&sol;headache-1540220&lowbar;1920&period;jpg"><img class&equals;"aligncenter size-full wp-image-371" src&equals;"https&colon;&sol;&sol;ustopbusiness&period;com&sol;wp-content&sol;uploads&sol;2020&sol;05&sol;headache-1540220&lowbar;1920&period;jpg" alt&equals;"" width&equals;"1920" height&equals;"1280" &sol;><&sol;a><&sol;p>&NewLine;<p><strong>No conclusive vaccines in the very short term<&sol;strong><&sol;p>&NewLine;<p>Amid all this confusion&comma; the European health agency announced on Thursday that any vaccine against &&num;8220&semi;Covid-19&&num;8221&semi; would not be ready before a year at best&comma; based on the data currently available on current research&period;<&sol;p>&NewLine;<p>&&num;8220&semi;We see the possibility that a vaccine will be ready to be licensed in a year from today if all goes according to plan&comma;&&num;8221&semi; said Marco Cavalieri&comma; head of biological health and immunization strategy agency&period;<&sol;p>&NewLine;<p><strong>Previous Sanofi cases<&sol;strong><&sol;p>&NewLine;<p>But this is not the first time that Sanofi has caused an outcry&period; Indeed&comma; the group has already been singled out by the Philippines in the case of the death of several children because of its vaccine against dengue Dengvaxia which is a tropical viral infection&period; But Sanofi has rejected these accusations&period;<&sol;p>&NewLine;<p>In addition&comma; Sanofi is on the list of defendants in the complaint by the State of Minnesota against three laboratories&comma; for having more than doubled the price of insulin in a short time&period;<&sol;p>&NewLine;<p>And not far away&comma; in February 2020&comma; the group was indicted for &&num;8220&semi;aggravated deception and&&num;8221&semi; unintentional injuries &&num;8220&semi;&comma; in the case of the anti-epileptic drug Depakine&period; Sanofi says that all its production process is clear and transparent&period;<&sol;p>&NewLine;<p><&excl;-- END THEIA POST SLIDER --><&sol;p>&NewLine;

Exit mobile version